Q8

Overview

Q8, an effective antiangiogenic drug, is a CysLt 1 antagonist (IC 50 of 4.9 μM). Q8 is sufficient to reduce cellular levels of NF-κB and calpain-2 and secreted levels of the proangiogenic proteins intercellular adhesion molecule-1, vascular cell adhesion protein-1, and VEGF .

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Leukotriene Receptor

Product Information

• Catalog No.: HY-127113
• CAS No.: 1541762-55-3
• Molecular Formula: C17H14ClNO2
• Molecular Weight: 299.75
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source